If I wanted some more, I know I wouldn't wait until tomorrow.

Then went from $1.60 to $8.00 immediately afterward:
And... held the $5.00 range for quite a few months after.

Awesome job Bob! $SVFC CEO Interview JUST OUT. MUST LISTEN: http://www.wallstreetnewscast.com/audio/svfc.wma

$SVFC CEO Interview JUST OUT. MUST LISTEN: http://www.wallstreetnewscast.com/audio/svfc.wma

$SVFC CEO Interview JUST OUT. MUST LISTEN: http://www.wallstreetnewscast.com/audio/svfc.wma

Bid is STACKED! Looking fantastic for EOD run.

Bring on the hot legs! LOL $SVFCeeeeeeeeeeeeeeeeeeee

Ah! We knew those whales would be showing up eh? $SVFC

WEEKLY CHART: agrees with you.
$SVFC

$SVFC bet we hit .10 tomorrow. This one has been a runner on Fridays.

$SVFC more starting to realize the $$$$$$$ potential here

$SVFC 27M Float BIOTECH undiscovered GEM!

$SVFC 27M Float BIOTECH undiscovered GEM!

$SVFC .10 is WEAK resistance. We'll march on to the teens toward .20. Watch!

$SVFC .10 is WEAK resistance. We'll march on to the teens toward .20. Watch!

$SVFC New HOD approach-eth!

$SVFC New HOD approach-eth!

$SVFC Medical Board of Advisors MUST SEE
$SVFC

Dr. James Andrews, The Andrews Institute, Washington Redskins
( http://www.cbssports.com/nfl/blog/eye-on-football/21937322/dr-james-andrews-calls-robert-griffin-iiis-recovery-superhuman )
Dr. Harold Bafitis, The Plastic Surgery Institute of The Palm Beaches
Dr. Peter Bruno, Internist, New York City
Dr. Greg Cavaliere, Orthopedic Surgeon, NY Rangers
Dr. Gil Chimes DC, DICBN, CCSP, CSCS Greenwich Sports Medicine in Greenwich, CT
Dr. Sydney Coleman, Tribeca Plastic Surgery, New York City
Dr. Mathew Cooper Aventura Chiropractor, Aventura, FL
Dr. Alberto Goldman, Plastic Surgeon, Brazil
Dr. Joshua Hackel, The Andrews Institute
Dr. Anthony V. Maddalo, Orthopedic Surgeon, NY Rangers
Dr. Frederick Nicola, D.I.S.C. Sports & Spine Center, Marian del Rey, Oakland/LA Raiders
Dr. Eric Richter, Neurologist, Chief LSU Health Sciences Center
Wilson Tawe, PhD, MBA Manager - Instrument FAS (North America) @ EMD Millipore (MERCK SUB)
Dr. Nicholas Toscano, Periodontist, Editor in Chief JIAD
Mr. Kevin Wilk, PT, DPT The Andrews Institute

$SVFC Medical Board of Advisors MUST SEE
$SVFC

Dr. James Andrews, The Andrews Institute, Washington Redskins
( http://www.cbssports.com/nfl/blog/eye-on-football/21937322/dr-james-andrews-calls-robert-griffin-iiis-recovery-superhuman )
Dr. Harold Bafitis, The Plastic Surgery Institute of The Palm Beaches
Dr. Peter Bruno, Internist, New York City
Dr. Greg Cavaliere, Orthopedic Surgeon, NY Rangers
Dr. Gil Chimes DC, DICBN, CCSP, CSCS Greenwich Sports Medicine in Greenwich, CT
Dr. Sydney Coleman, Tribeca Plastic Surgery, New York City
Dr. Mathew Cooper Aventura Chiropractor, Aventura, FL
Dr. Alberto Goldman, Plastic Surgeon, Brazil
Dr. Joshua Hackel, The Andrews Institute
Dr. Anthony V. Maddalo, Orthopedic Surgeon, NY Rangers
Dr. Frederick Nicola, D.I.S.C. Sports & Spine Center, Marian del Rey, Oakland/LA Raiders
Dr. Eric Richter, Neurologist, Chief LSU Health Sciences Center
Wilson Tawe, PhD, MBA Manager - Instrument FAS (North America) @ EMD Millipore (MERCK SUB)
Dr. Nicholas Toscano, Periodontist, Editor in Chief JIAD
Mr. Kevin Wilk, PT, DPT The Andrews Institute

Medical Board of Advisors MUST SEE
$SVFC

Dr. James Andrews, The Andrews Institute, Washington Redskins
( http://www.cbssports.com/nfl/blog/eye-on-football/21937322/dr-james-andrews-calls-robert-griffin-iiis-recovery-superhuman )
Dr. Harold Bafitis, The Plastic Surgery Institute of The Palm Beaches
Dr. Peter Bruno, Internist, New York City
Dr. Greg Cavaliere, Orthopedic Surgeon, NY Rangers
Dr. Gil Chimes DC, DICBN, CCSP, CSCS Greenwich Sports Medicine in Greenwich, CT
Dr. Sydney Coleman, Tribeca Plastic Surgery, New York City
Dr. Mathew Cooper Aventura Chiropractor, Aventura, FL
Dr. Alberto Goldman, Plastic Surgeon, Brazil
Dr. Joshua Hackel, The Andrews Institute
Dr. Anthony V. Maddalo, Orthopedic Surgeon, NY Rangers
Dr. Frederick Nicola, D.I.S.C. Sports & Spine Center, Marian del Rey, Oakland/LA Raiders
Dr. Eric Richter, Neurologist, Chief LSU Health Sciences Center
Wilson Tawe, PhD, MBA Manager - Instrument FAS (North America) @ EMD Millipore (MERCK SUB)
Dr. Nicholas Toscano, Periodontist, Editor in Chief JIAD
Mr. Kevin Wilk, PT, DPT The Andrews Institute

READ THE DD! UNDISCOVERED GEM is what's going on with $SVFC.

$SVFC RSI nowhere near the MOMO Zone yet!

$SVFC RSI nowhere near the MOMO Zone yet!

$SVFC Stockscores CHART (Another Perspective)___>
A Beaut no matter how you look at it. $SVFC

$SVFC Stockscores CHART (Another Perspective)___>
A Beaut no matter how you look at it. $SVFC

Stockscores CHART (Another Perspective)___>
A Beaut no matter how you look at it. $SVFC

SVFC Open House Tour Event

SOURCE:
http://www.wallstreetnewscast.com/profile/svfc.html

Very rarely do we get the chance to tour a companies operation facilities. Since based in midtown Manhattan we had the chance to tour SVFC medical treatment

facilities, and can say first hand that their facilities were very impressive. Not only were their people visiting for basic cosmetic treatments, which

the company uses to generate revenue and offset operational costs, but the back-side treatment facilities were quit large and impressive. There were a

number of completed clean and professional minimal surgical treatment rooms, offices, and very impressive and FDA compliant stem cell extraction processing

room, which was managed by very experienced and professional personal.

The Company is working on conducting an open house event where shareholders, and institutional investors will be invited to tour their facilities on Park

Avenue, and meet the executives from IntelliCell. An announcement of this upcoming open house could be released in the coming days, and to potentially attend

this event in NYC you can register here to request more information.

All in all, SVFC isn't one of your regular penny stock, or run of the mill R&D stem cell stocks. SVFC has a very impressive treatment facility that will

not only manufacture stem cells through their now patented process, but treat patients as well. This places SVFC as one of the very few stem cell treatment

and
manufacturers in the US, and they are always open to provide guided tours if you ever find yourself in New York City. This is defiantly one to watch.

Shake-n-Bake... and then upward.

$SVFC - See you at .10 Doc.

SVFC with HUGE Biotechs in MAXIM GROUP REPORT:

http://www.filesanywhere.com

LOGIN WITH:

User: Victor07
Password: Anna249249


News: http://www.otcmarkets.com/news/otc-market-headline?id=15261281

Companies mentioned include:
Athersys, Inc. (ATHX) – $1.68 – Buy
Baxter (BAX) – $69.88 – NR
Capricor (private)
Cardio3 Biosciences (private)
Cytomedix (CMXI) – $0.42 – NR
Cytori Therapeutics (CYTX) – $2.43 – Buy
Dendreon (DNDN) – $4.48 – Sell
IntellicellBioScience (SVFC)-$0.05 - NR
Lonza (LONN.VX) – CHF72.30 -NR
Mesoblast Ltd. (MBLTY) – $25.14 – Buy
NeoStem, Inc. (NBS) – $0.57– NR
Osiris (OSIR) – $10.40 – NR
Pfizer (PFE) – $27.97 – NR
Pluristem (PSTI) – $2.98 – Hold
Teva Pharmaceuticals (TEVA) – $38.94 – Buy
*Closing prices (7/05/2013)

SVFC with HUGE Biotechs in MAXIM GROUP REPORT:

http://www.filesanywhere.com

LOGIN WITH:

User: Victor07
Password: Anna249249


News: http://www.otcmarkets.com/news/otc-market-headline?id=15261281

Companies mentioned include:
Athersys, Inc. (ATHX) – $1.68 – Buy
Baxter (BAX) – $69.88 – NR
Capricor (private)
Cardio3 Biosciences (private)
Cytomedix (CMXI) – $0.42 – NR
Cytori Therapeutics (CYTX) – $2.43 – Buy
Dendreon (DNDN) – $4.48 – Sell
IntellicellBioScience (SVFC)-$0.05 - NR
Lonza (LONN.VX) – CHF72.30 -NR
Mesoblast Ltd. (MBLTY) – $25.14 – Buy
NeoStem, Inc. (NBS) – $0.57– NR
Osiris (OSIR) – $10.40 – NR
Pfizer (PFE) – $27.97 – NR
Pluristem (PSTI) – $2.98 – Hold
Teva Pharmaceuticals (TEVA) – $38.94 – Buy
*Closing prices (7/05/2013)

SVFC 6/13 - IntelliCell Receives US Patent for its Stem Cell Extraction Technology

NEW YORK, June 13, 2013 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that

its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated

vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an

innovative mechanical method for the separation of stromal vascular fraction cells from adipose (fat) tissue, without the use of enzymes. Vascular cells

derived by IntelliCell's proprietary method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic

procedures. Investors can access the published patent at the US Patent website by entering the patent # 8,440,440. Link to patent

website: http://patft.uspto.gov/netahtml/PTO/srchnum.htm

IntelliCell's Chairman and CEO, Dr. Steven Victor, stated "Our Company is very pleased to announce today that with the publishing of our patent,

our technology is now protected and we expect our international patent publication in a short time."

About IntelliCell BioSciences, Inc.

IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative and preventative conditions

of disease states with high unmet clinical needs. The Company has several patent-pending applications including the patent that was recently published, an

industry unique method of obtaining autologous stromal vascular fraction cells (SVF) cells from the vasculature surrounding adipose tissue containing adult

stem cells and a robust population of regenerative healing cells. The Company is also pioneering the development of autologous and allogeneic cells from

living and non-living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the

treatment of osteoarthritis, multiple sclerosis, lower limb ischemic wounds, and gum regeneration in the oral cavity as well as medical aesthetics. The

Company has developed a first in class cGTP cellular processing facility in New York City, purpose built and designed to be fully integrated into an

ambulatory surgery center.

Forward-Looking Statements

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any

statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project,"

"intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could,"

"would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and

uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking

statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results

may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and

uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions,

activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential

factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and

Exchange Commission.

Contacts:
Anna Rhodes, IntelliCell BioSciences, Inc. Phone: (646) 576-8710 ?
Email: arhodes@intellicellbiosciences.com

Melissa Diaz?, South Street Media, Inc. Phone: (917) 937-8968
Email: info@southstreetmedia.com

SOURCE IntelliCell BioSciences, Inc.

Copyright 2013 PR Newswire

$SVFC Up 35% heading for .10......

$SVFC Up 35% heading for .10......

$SVFC TONS of room to go. Annotated Chart_____>
$svfc

$SVFC TONS of room to go. Annotated Chart_____>
$svfc

TONS of room to go. Annotated Chart_____>
$svfc

$SVFCeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee!!!!!!!!!!!!!!!!!

KEEP CHECKING THIS SVFC CHART FOLKS_____>
$SVFC has busted the biggest resistance we had.
AND .10 is NOT a big resistance. And the 200MA is at .13. Up, Up, Up!

HOLDING ALL! Look at that BID SUPPORT! SVFCeeeeeeeeeeeeee